Skip to main content
IDXX logo

IDXX · Idexx Laboratories Inc · Documents

Track IDXX — free
Market Cap
$55.20B
Shares
78.79M
Volume · Nov 16 491.5K Avg daily vol (3M) 567.85K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021
Nov 2
Quarterly report 10-Q FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $810.42M ▲ 12.3% Net income $175.24M ▲ 19.8% Diluted EPS $2.03 ▲ 20.1%
Jul 30
Quarterly report 10-Q FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $826.14M ▲ 29.6% Net income $202.58M ▲ 36.0% Diluted EPS $2.34 ▲ 36.0%
May 4
Quarterly report 10-Q FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $777.71M ▲ 24.2% Net income $204.26M ▲ 82.7% Diluted EPS $2.35 ▲ 82.2%
Feb 12
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $2.71B ▲ 12.5% Net income $581.78M ▲ 36.0% Diluted EPS $6.71 ▲ 37.2%
2020
Oct 29
Quarterly report 10-Q FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $721.79M ▲ 19.2% Net income $146.22M ▲ 34.3% Diluted EPS $1.69 ▲ 36.3%
Jul 31
Quarterly report 10-Q FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $637.59M ▲ 2.8% Net income $148.94M ▲ 18.5% Diluted EPS $1.72 ▲ 20.3%
Apr 30
Quarterly report 10-Q FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $626.34M ▲ 8.7% Net income $111.83M ▲ 8.9% Diluted EPS $1.29 ▲ 10.3%
Feb 14
Annual report 10-K FY2019, ended Dec 31
Annual report for FY2019
Revenue $2.41B ▲ 8.8% Net income $427.72M ▲ 13.4% Diluted EPS $4.89 ▲ 14.8%
Showing 101–135 of 135 documents
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 1100 filings 1044 filers Visit website Investor relations